The Future: Multi-Agonist Era Tirzepatide Dual agonist: GLP-1 + GIP Produces: Exceptional HbA1c reduction Major weight loss Retatrutide Triple agonist: GLP-1 + GIP + Glucagon receptor Early trials demonstrated unprecedented weight loss results approaching bariatric surgery outcomes
Unlike exogenous GH, sermorelin does not bypass the hypothalamic-pituitary axis, so side effects such as carpal tunnel syndrome, insulin resistance, edema, and joint pain are rare
Do not remove your pen in its original packaging to protect it from light or high temperature
It has a slightly sweet, malty, flavor and is a great compliment to Cacao, Vanilla and Maca
Wegovy is initiated at 0.25 mg weekly and gradually titrated to the target dose of 2.4 mg weekly as tolerated
Bioinformatics 26 , 966968 (2010)